Cathy Seiler, PhD, is currently the Director of Business Planning and Operations Lead (Chief of Staff) for Translational Medicine Oncology at AstraZeneca. They have a diverse background in supporting critical research within scientific and clinical environments, with previous roles including leadership positions at H3 Biomedicine and St. Joseph's Hospital and Medical Center. Cathy has been instrumental in the management of biobanks, grant funding, and operational excellence, contributing significantly to initiatives that secure millions in funding and establish essential research practices. Their academic credentials include a BA in Biochemistry and Molecular Biology from Boston University and a PhD in Cell and Molecular Biology from Cold Spring Harbor Laboratory.
This person is not in any teams
This person is not in any offices